World Stem Cell Summit
  • About WSCS
    • About Us
    • Past Speakers
    • Annual Regenerative Medicine Essentials Course
    • 2023 Public Day
    • Symposium Intersection of RegMed & Healthspan
    • Effective Patient Advocacy
    • Regenerative Medicine & the Commercial Space Economy
    • Hot Topics in 2023 at World Stem Cell Summit
  • Partners/Sponsors
    • Partners/Sponsors
    • Sponsorship Opportunities
  • Upcoming Events
  • News & Media
    • News and Opinions
    • WSCS 2023 Photos
    • WSCS Video
  • Contact Us
Select Page
Pfizer Makes Foray Into CRISPR, Inking .35 Billion Deal With Beam Therapeutics

Pfizer Makes Foray Into CRISPR, Inking $1.35 Billion Deal With Beam Therapeutics

by admin | Jan 12, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By: ALLISON GATLIN – Investors.com – 01/10/2022 (link to article) Pfizer (PFE) is entering the CRISPR space through a $1.35 billion deal with Beam Therapeutics (BEAM), the companies announced Monday. But Beam stock fell on the deal. Beam is using CRISPR...
Auto Draft

For everything there is a season

by admin | Dec 24, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

As 2021 draws to a close, we celebrate the first decade of STEM CELLS Translational Medicine (SCTM) with gratitude to our devoted editors, reviewers, authors, and of course, our global loyal readership … all of you are a vital part of this first decade’s...
Stem Cell Therapy Safe, Shows Potential to Slow Progression in Trial

Stem Cell Therapy Safe, Shows Potential to Slow Progression in Trial

by admin | Dec 8, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Margarida Maia, PhD Repeat injections of mesenchymal stem cells (MSCs) into the spinal canal were safe and well tolerated in patients with amyotrophic lateral sclerosis (ALS), and showed potential to significantly slow the rate of disease progression, a small Phase...
Type 1 Diabetes Trial Tests Insulin-Secreting Implants Derived from Stem Cells

Type 1 Diabetes Trial Tests Insulin-Secreting Implants Derived from Stem Cells

by admin | Dec 7, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

For the first time, scientists have derived insulin-secreting pancreatic endoderm cells from human pluripotent stem cells (PSCs), grafted these cells into 26 patients with type 1 diabetes, and demonstrated insulin secretion. The ongoing multicenter clinical trial aims...
New potential drugs for muscle dystrophy found using stem cells

New potential drugs for muscle dystrophy found using stem cells

by admin | Dec 4, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

November 29, 2021 – Kyoto, Japan – (Link to Article) Muscular dystrophy describes a group of genetic diseases in which muscles progressively weaken and degenerate, with Duchenne muscular dystrophy (DMD) being the most common. There are no curative...
“World’s first” 3D printed immunized skin model enables cold plasma wound healing treatment for burns

“World’s first” 3D printed immunized skin model enables cold plasma wound healing treatment for burns

by admin | Dec 3, 2021 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

The NOVOPLASM consortium has announced it is the “first in the world” to develop cold plasma technology for the treatment of infected burns and the wound healing of skin grafts. Regenerative medicine firm CTIBIOTECH, the French Armed Forces Biomedical Research...
Page 129 of 176« First«...102030...127128129130131...140150160...»Last »

Recent Posts

  • New MRI technique lights up ‘zombie cells’ that contribute to arthritis
  • Gene Therapy Restores Immune Function in Children With Rare Disorder
  • May is Huntington’s Disease Awareness Month
  • Microgravity Could Be the Key to Developing New Therapies for Neurogenerative Diseases
  • Expert Q&A: ‘Invisible’ Stem Cells
  • iPS Cell Research Can Give Japan Lead in Regenerative Medicine
World Stem Cell Summit Logo - White version
Copyright © 2025 Regenerative Medicine Foundation, All rights reserved.
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow